TLB-33 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

3,106 results for “TLB-33”

Trials

View all 1477 →

Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State

12 participants · First posted Nov 21, 2025

R61/33 - VR Study Phase 4

252 participants · First posted Sep 12, 2025

UARK 2003-33, Total Therapy III

303 participants · First posted Apr 29, 2004

Drugs

View all 440 →

TLB-003

TLB-001

TLB-002

Organizations

View all 102 →

河南开元药业有限公司漯河分公司

Wyeth LLC

United States

Teclison Ltd.

United States

News

View all 1087 →

Tolerance Bio Licenses Anti-IL-33 Antibody TLB-33 from Tanabe Pharma in Deal Worth Up to $560M

RK-33 Eliminates Bone Metastases in Breast Cancer Models

Alnylam Reports Strong 33% Growth, Sets Ambitious $2.25B Revenue Target for 2025

Page 1 of 311